Imricor Medical Systems Valuation Multiples

Imricor Medical Systems Overview

About Imricor Medical Systems

Imricor Medical Systems Inc is a medical device company that develops MRI-guided technology to address issues with traditional X-ray ablation procedures. Its principal business activities are designing, manufacturing, and selling MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias. The company's products include the Advantage-MR EP Recorder/Stimulator, Vision-MR Ablation Catheter, and Vision-MR Dispersive Electrode. Geographically, the company generates maximum revenue from Europe, followed by the Middle East and the United States.

Founded

2006

HQ

Employees

N/A

Website

imricor.com

Sectors

Medical DevicesBioTechLongevity

Financials (LTM)

Revenue: $1M

EBITDA: ($21M)

EV

$434M

Valuation Multiples

Multiples.vc

Start free trial

Imricor Medical Systems Financials

Imricor Medical Systems reported last 12-month revenue of $1M and negative EBITDA of ($21M).

In the same LTM period, Imricor Medical Systems generated ($1M) in gross profit, ($21M) in EBITDA losses, and had net loss of ($24M).

Imricor Medical Systems P&L

In the most recent fiscal year, Imricor Medical Systems reported revenue of $959K and EBITDA of ($29M).

Imricor Medical Systems expects next 12-month revenue of XXX and NTM EBITDA of XXX

Imricor Medical Systems Stock Performance

Imricor Medical Systems has current market cap of $455M, and enterprise value of $434M.

Imricor Medical Systems' stock price is $1.42.

Imricor Medical Systems Valuation Multiples

Imricor Medical Systems trades at 412.2x EV/Revenue multiple, and (20.4x) EV/EBITDA.

Imricor Medical Systems Financial Valuation Multiples

As of March 28, 2026, Imricor Medical Systems has market cap of $455M and EV of $434M.

Equity research analysts estimate Imricor Medical Systems' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Imricor Medical Systems has a P/E ratio of (18.6x).

Imricor Medical Systems Margins & Growth Rates

Imricor Medical Systems' revenue in the last 12 month grew by 365%.

Imricor Medical Systems' rule of 40 is (1656%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Imricor Medical Systems' rule of X is (1109%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Imricor Medical Systems Public Comps

See public comps and valuation multiples for other Medical Devices comps.

Imricor Medical Systems M&A Activity

Imricor Medical Systems acquired XXX companies to date.

Last acquisition by Imricor Medical Systems was on XXXXXXXX, XXXXX. Imricor Medical Systems acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Imricor Medical Systems Investment Activity

Imricor Medical Systems invested in XXX companies to date.

Imricor Medical Systems made its latest investment on XXXXXXXX, XXXXX. Imricor Medical Systems invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).